SAFE Financing Transactions

How to map conversion triggers and outcomes for SAFE Financing Transactions

Map SAFE conversion triggers, pricing, share classes, exit proceeds, and open issues with a company-side workflow and copyable conversion checklist.

October 18, 2026  ·  10 min read
Book a Demo →

Map SAFE conversion by treating each executed instrument as a set of conditional outcomes, not simply a future equity percentage. Identify the operative documents, extract event definitions, connect each trigger to its pricing and payment provisions, and test those provisions against the proposed transaction and capitalization records. The deliverable is a source-linked conversion checklist showing which SAFEs convert, produce payment entitlements, remain outstanding, or terminate; what shares or proceeds investors may receive; and which factual, interpretive, or authorization questions counsel must resolve before the company acts.

When to use this workflow

Use this review when a company with outstanding SAFEs anticipates a priced financing, acquisition, listing, IPO, or dissolution—or needs to determine whether a proposed transaction leaves its SAFEs outstanding. Company counsel and finance should use the same transaction assumptions and document set.

The scope is conversion and related outcomes, not a complete financing closing checklist. This guide uses a US orientation, with Delaware corporate authorization where identified. Other formation jurisdictions require separate analysis. Outcomes depend on executed language, governing law, transaction facts, and related agreements. The workflow recommendations below are review practices, not independent legal requirements.

What you need

Collect the evidence determining the event and its consequences:

  • Executed SAFEs, amendments, waivers, consents, and side letters, including participation and most-favored-nation provisions.
  • Current charter documents, relevant corporate approvals, and proposed conversion-share terms.
  • Capitalization records covering issued shares, options, promised options, reserved pools, SAFEs, notes, and other potentially included securities.
  • Contractual purchase amounts and subscription or funding records, with discrepancies identified.
  • Proposed transaction documents showing price, security class, closing sequence, consideration, and sale or listing structure.
  • Debt and material-contract restrictions potentially affecting issuance, conversion, or change-of-control approvals.

Assign stable document IDs. Preserve superseded versions without presenting them as operative. Ask the company custodian to distinguish missing documents from confirmed nonexistence, and keep forecasts separate from signed evidence.

Use the template

Use the SAFE Financing Transactions — SAFE conversion checklist below. You can copy this table into your working document or spreadsheet. Create one row per instrument and scenario so alternative events do not become competing conclusions in one record.

SAFE / source Scenario / trigger Evidence / status Price / inputs Outcome / priority Dependencies Action / owner Closure proof

In SAFE / source, identify the instrument and exact clause or page, including amendments. Evidence / status distinguishes verified facts, assumptions, missing evidence, and interpretive questions. Price / inputs may refer to model cells, but each material input needs a definition and source.

Record the receiving security or payment entitlement in Outcome / priority, not just a share count. Use Dependencies for unresolved definitions, approvals, participation rights, and documentation. Closure proof identifies what establishes completion or a verified no-trigger conclusion. Record provisional status, severity, and target dates in the action cell where needed; distinguish approval of a projection from evidence of actual issuance or payment.

Step by step

1. Establish the operative instrument set

Reconcile the SAFE register against executed documents and capitalization records. Identify each investor, purchase amount, controlling version, amendment, and related side letter. Matching filenames or valuation caps do not establish identical terms.

Check whether an MFN election, amendment, or waiver changed the provisions being mapped. An unsigned replacement draft does not establish an effective amendment. Investigate differences between recorded investment amounts and contractual purchase amounts rather than silently selecting one.

Record: controlling document IDs and clause references, with an owner for each missing or conflicting document. Mark affected conclusions provisional.

2. Connect event definitions to transaction facts

Read each operative event clause with its incorporated definitions. Test equity financing, acquisition, direct listing, IPO, dissolution, and no-trigger scenarios separately. Some events may share a defined term; others may not appear.

Extract actual thresholds and timing requirements. Distinguish signing from closing, and initial from subsequent closings. Map each element to transaction evidence rather than relying on the transaction’s commercial label.

The CapCO2 filed SAFE form, §1(a) illustrates conversion at the initial Equity Financing closing. That is wording to compare, not a rule for every SAFE. The filing is a contractual example from a crowdfunding context, not evidence of executed investor terms or SEC approval.

Record: relevant definitions, supporting transaction facts, missing facts, and a supported or conditional trigger assessment.

3. Reconstruct pricing from defined inputs

Separate cap-only, discount-only, and combined instruments. Preserve the stated Discount Rate and separately calculate the economic discount. Read how the instrument selects between alternatives; do not assume benefits stack.

For example, the CapCO2 form, §2 selects the Safe Price or Discount Price producing more shares and calculates Discount Price by multiplying the financing share price by the stated rate.

Trace capitalization denominators to their definitions, addressing option pools, promised options, and other convertibles. YC explains that its post-money cap is post-SAFE money, not post-priced-round money; use that explanation only where the executed design supports it (YC User Guide).

Record: sourced inputs, formulas, model-cell references, alternative prices, selected price, and unresolved denominator assumptions.

4. Map securities, payment entitlements, and priority

For financing scenarios, identify the receiving security and its rights. Compare the conversion provision with proposed charter terms, including any distinct conversion series. Follow the instrument’s fractional-share treatment; flag silence rather than inventing a rounding convention.

For exits, distinguish the entitlement formula from available proceeds. Compare cash-out and as-converted alternatives where required, then examine priority and competing claims. The CapCO2 form, §§1(b)–(d) distinguishes liquidity and dissolution outcomes and subjects distributions to contractual priority. It does not guarantee recovery or establish insolvency law.

Stress-test insufficient proceeds. For a no-trigger scenario, identify which provisions remain operative.

Record: security or payment formula, priority source, proceeds assumptions, and unresolved allocation questions.

5. Identify authorization and documentation dependencies

Separate contractual triggers from corporate authorization. For Delaware corporations, assess whether DGCL §157 applies to the particular SAFE and its authorizing resolutions. Sections 152–153 address stock issuance consideration and the par-value floor. These provisions alone do not establish sufficient authorized shares or valid preferred-stock terms.

Compare the modeled issuance against the charter, approvals, and any delegated authority. Read investor obligations to execute financing documents, including protections and limitations. Do not reclassify every documentation obligation as a condition precedent without textual support.

Review participation side letters separately. YC’s optional pro rata side letter concerns participation in the financing where its SAFE converts, but executed arrangements may differ (YC User Guide). Model new participation purchases separately from conversion shares.

Record: each dependency’s source, classification, owner, and required resolution evidence.

6. Test termination and surviving obligations

Do not equate a forecast trigger with completed termination. Determine whether termination requires issuance, payment, reservation of proceeds, or another act. Examine side letters separately for continuing obligations.

The CapCO2 form, §1(e) links termination to conversion-share issuance or payment or reservation of applicable proceeds, while preserving obligations arising from prior breach or noncompliance. Apply other wording on its own terms.

Record: termination requirements, completion evidence, potentially surviving obligations, and confirmation responsibility. Keep projected outcomes open until supported.

7. Reconcile and approve the decision map

Have a second reviewer trace material formulas to instrument definitions and company records. Reconcile aggregate conversion shares with the proposed capitalization schedule. In proceeds scenarios, apply consistent assumptions and ensure the model does not allocate the same funds twice.

Separate confirmed conclusions from conditional ones. State how an unresolved input could change the result. Assign commercial choices to the authorized company decision-maker and legal interpretation questions to counsel.

Record: reviewer disposition, approved assumptions, unresolved issue owners, and evidence required before a provisional result enters final transaction documents.

Worked example

Fictional scenario: Juniper Circuit, Inc., a Delaware corporation, is considering a preferred financing at $2.00 per share and an alternative acquisition. All parties, documents, amounts, and clauses below are invented.

SAFE J-01 has a $300,000 purchase amount, an $8 million cap, and an 85% Discount Rate. Its terms select the lower applicable price and convert at the initial financing closing into Series A-S shares. Model M-01 provisionally uses 5 million shares in its contract-defined denominator, producing a $1.60 cap price. Promised-option records remain unverified. The discount price is $1.70.

SAFE J-02 represents $200,000 and, on an acquisition closing, provides the greater of its purchase amount and an as-converted amount, subject to specified priority. There are no definitive acquisition terms or proceeds schedule. The acquisition is an alternative, not a later event in the financing scenario.

SAFE / source Scenario / trigger Evidence / status Price / inputs Outcome / priority Dependencies Action / owner Closure proof
J-01 §§1(a), 2 Initial financing closing F-01 draft; prospective M-01!B8: $1.60 cap; B9: $1.70 discount Provisional 187,500 Series A-S shares Promised options unverified; charter pending Finance verifies denominator; counsel verifies class Approved model, then issuance record
J-02 §§1(b), 1(d) Alternative acquisition closing Sale terms and proceeds schedule absent $200,000 comparator; as-converted amount unknown Greater contractual amount, subject to priority; recovery unknown Consideration and competing claims unresolved Deal counsel obtains proceeds model Reviewed allocation, then payment evidence
J-01 §§1(a), 1(e) Financing signed, not closed F-01 execution evidence assumed Signing does not activate conversion formula Remains outstanding under stated facts Confirm no other trigger or amendment Counsel verifies event history Sourced no-trigger conclusion

Dividing $300,000 by $1.60 produces 187,500 shares, but not an issuance-ready instruction. A verified denominator of 4 million shares would instead produce a $2.00 cap price, making the $1.70 discount price preferable under J-01’s fictional terms. The missing records can therefore change the selected pricing route, not merely the share count.

The J-02 row prevents treating its purchase amount as guaranteed recovery. The final row prevents removing J-01 from the outstanding register merely because financing documents were signed.

Common mistakes

  • Applying one formula across all SAFEs. Compare operative definitions, amendments, and side letters before grouping instruments.
  • Reading an 85% rate as an 85% discount. Preserve the rate and show the calculation: the example gives a 15% economic discount.
  • Treating post-money ownership as fixed after new financing money. Reconstruct the contractual denominator and model new-money dilution separately.
  • Recording purchase amount as guaranteed exit recovery. Review alternative entitlements, priority, available proceeds, and missing allocation evidence.
  • Closing rows when an event is forecast. Distinguish approved projections from evidence of actual conversion, payment, and termination.

Final quality check

Accept the map only when:

  • Every outstanding SAFE is reconciled to operative documents and side letters.
  • Each scenario cites its event definition and outcome clause.
  • Material pricing inputs have sources or assigned verification tasks.
  • Receiving securities, payment priority, and proceeds assumptions are separately recorded.
  • Authorization questions are distinguished from contractual triggers and internal recommendations.
  • Termination conclusions identify completion evidence and surviving obligations.
  • Source references and calculations are checked, with material open issues resolved or expressly assigned and affected outputs marked provisional.

Complete the workflow with DecoverAI

DecoverAI is the Legal Intelligence Platform for litigation and transactions. Contract review can support clause-level review: in Word, choose the company as represented party and provide transaction-specific instructions. Findings quote clauses, rank severity, locate text, and identify missing language as not present. Lawyers edit or insert suggestions as ordinary tracked changes in the signed-in Word user’s name, or dismiss findings with reasons. Tabular review supports comparison across documents; due diligence classification can organize the instrument set and prioritize human review. The checklist, calculations, and legal conclusions remain counsel-controlled. Book a demo to discuss this workflow.

Frequently asked questions

Can identical caps justify combining investors into one row?

No. Compare event definitions, purchase amounts, pricing mechanics, amendments, and side letters first. Preserve investor-level source records even when instruments share a calculation method.

Should IPO and direct-listing scenarios be separate?

Yes. Test whether each instrument expressly covers them, includes them within another definition, or leaves an interpretive question. Similar commercial objectives do not establish identical contractual treatment.

What if cap-table records conflict with the SAFE definition?

Preserve the contractual definition and flag the discrepancy. Obtain underlying securities and option records, then rebuild the defined denominator. A convenient cap-table total is not a substitute for required inputs.

Does automatic conversion eliminate follow-up work?

No. Determine contractual timing, then verify calculations, receiving securities, authorization, documentation, and issuance evidence. Automatic conversion language does not resolve every implementation or termination question.

Sources

This guide is general information about legal workflows, not legal advice for any matter. It was drafted and reviewed with AI assistance. The worked example is fictional. Contract rights and procedure depend on the governing law, the actual wording, and the facts, so check the cited sources and the rules that apply in your jurisdiction before relying on it.

Run this workflow in DecoverAI

Clause-quoted findings, missing-language flags, and tracked changes in your name — with your team deciding every call. Plans from $299 per seat per month, SOC 2 Type II certified.

Book a demo
to learn more.
Book a Demo